Recombinant Erwinia asparaginase
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant Erwinia asparaginase, covering 2026-02-06 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia [Phase 1]